CX Institutional Raises Stock Holdings in Select Medical Holdings Co. (NYSE:SEM)

CX Institutional increased its position in Select Medical Holdings Co. (NYSE:SEM) by 8.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 37,904 shares of the health services provider’s stock after purchasing an additional 3,083 shares during the period. CX Institutional’s holdings in Select Medical were worth $714,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Geode Capital Management LLC grew its stake in Select Medical by 2.0% in the third quarter. Geode Capital Management LLC now owns 2,442,321 shares of the health services provider’s stock worth $85,180,000 after purchasing an additional 46,880 shares during the period. Principal Financial Group Inc. lifted its holdings in shares of Select Medical by 6.7% during the third quarter. Principal Financial Group Inc. now owns 2,357,823 shares of the health services provider’s stock valued at $82,208,000 after purchasing an additional 147,032 shares in the last quarter. Point72 Asset Management L.P. lifted its holdings in shares of Select Medical by 144.2% during the third quarter. Point72 Asset Management L.P. now owns 2,059,791 shares of the health services provider’s stock valued at $71,825,000 after purchasing an additional 1,216,263 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its holdings in shares of Select Medical by 1.5% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,646,320 shares of the health services provider’s stock valued at $57,407,000 after purchasing an additional 24,439 shares in the last quarter. Finally, Victory Capital Management Inc. lifted its holdings in Select Medical by 0.6% in the third quarter. Victory Capital Management Inc. now owns 1,181,078 shares of the health services provider’s stock valued at $41,184,000 after acquiring an additional 7,372 shares during the period. 89.48% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, VP Robert G. Breighner, Jr. sold 4,989 shares of the stock in a transaction dated Wednesday, December 4th. The stock was sold at an average price of $19.95, for a total transaction of $99,530.55. Following the completion of the sale, the vice president now owns 30,356 shares in the company, valued at approximately $605,602.20. This trade represents a 14.12 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Marilyn B. Tavenner sold 32,000 shares of the stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $21.09, for a total value of $674,880.00. Following the sale, the director now owns 22,000 shares of the company’s stock, valued at $463,980. This represents a 59.26 % decrease in their position. The disclosure for this sale can be found here. 19.14% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

A number of research firms have weighed in on SEM. Royal Bank of Canada increased their target price on Select Medical from $40.00 to $47.00 and gave the company an “outperform” rating in a report on Monday, November 4th. UBS Group lowered their target price on Select Medical from $40.00 to $21.00 and set a “neutral” rating on the stock in a report on Friday, January 3rd. Benchmark downgraded Select Medical from a “buy” rating to a “hold” rating in a report on Monday, November 25th. Finally, StockNews.com downgraded Select Medical from a “buy” rating to a “hold” rating in a report on Wednesday, January 15th. Three analysts have rated the stock with a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $39.50.

Select Medical Stock Performance

Shares of SEM opened at $19.69 on Friday. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 1.37. The business has a 50-day simple moving average of $21.64 and a two-hundred day simple moving average of $30.51. The stock has a market cap of $2.55 billion, a price-to-earnings ratio of 9.20, a PEG ratio of 0.65 and a beta of 1.45. Select Medical Holdings Co. has a 52 week low of $18.02 and a 52 week high of $40.98.

Select Medical (NYSE:SEM) last issued its quarterly earnings results on Thursday, October 31st. The health services provider reported $0.43 EPS for the quarter, topping analysts’ consensus estimates of $0.36 by $0.07. Select Medical had a return on equity of 15.99% and a net margin of 3.97%. The business had revenue of $1.76 billion during the quarter, compared to analysts’ expectations of $1.74 billion. During the same quarter in the prior year, the business posted $0.46 earnings per share. The business’s quarterly revenue was up 5.7% on a year-over-year basis. On average, analysts expect that Select Medical Holdings Co. will post 1.97 EPS for the current year.

Select Medical Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, November 26th. Investors of record on Wednesday, November 13th were given a dividend of $0.125 per share. This represents a $0.50 annualized dividend and a dividend yield of 2.54%. The ex-dividend date was Wednesday, November 13th. Select Medical’s dividend payout ratio is currently 23.36%.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.